TScan Therapeutics had a revenue of 665.00K in the quarter ending Dec 31, 2024, with -36.61%. This bring the company's revenue in the last twelve months to 2.82M, Increased -69.92%. In the fiscal year ending Dec 31, 2024, TScan Therapeutics had annual revenue of 2.82M with -86.62% growth.